Nurse calls from home: a new way to manage kidney disease?
NCT ID NCT07669142
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 9-week tele-nursing program—including education, phone or online check-ins, and counseling—can improve quality of life and health outcomes for people with stage 3 or 4 chronic kidney disease who are not yet on dialysis. Researchers will compare 66 participants who receive the program plus usual care against those who get usual care alone. Outcomes like quality of life, medication adherence, and lab values will be measured over 6 months.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Structured Telenursing Education, Counseling, and Follow-up Program
- What this could lead to
- If it works, this could show that remote nursing support helps people with chronic kidney disease feel better and manage their condition more effectively.
- What could go wrong
- This is a small, early-stage study with only 66 participants. The results may not apply to everyone, and the tele-nursing program may not lead to significant improvements over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
66 people
The number who actually took part.
- Started
-
May 2026
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being 18 years of age or older Having a diagnosis of stage 3A, 3B, or 4 chronic kidney disease Having an estimated glomerular filtration rate between 15 and 59 mL/min/1.73 m² Being followed in the nephrology outpatient clinic for at least 3 months Not receiving dialysis treatment Being able to communicate in Turkish Having access to a telephone or smart device suitable for tele-nursing follow-up Being able to participate in telephone, messaging, or online follow-up Voluntarily agreeing to participate in the study Providing informed consent Exclusion Criteria: * Having stage 1,2 and 5 chronic kidney disease Receiving hemodialysis or peritoneal dialysis treatment Having a history of acute kidney injury within the last 3 months Having a terminal illness Having severe cognitive impairment, psychiatric disorder, or communication problem that prevents participation in the study Having hearing, speech, or visual impairment that prevents effective tele-nursing communication Not having access to the required communication tools for remote follow-up Participating in another interventional study that may affect the outcomes of this research Refusing to participate in the study Withdrawing informed consent during the study period
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD stage 3/4 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsun City Hospital, Samsun, 55000, Türkiye (Turkey)
Samsun, 55000, Turkey (Türkiye)